A kind of small molecule gel and preparation method and solid-liquid interconversion gel preparation for gynecology
A technology of molecular gels and gel preparations, applied in the field of gynecological pharmaceuticals, can solve the problems of unsatisfactory stability of small molecule gels, uneven distribution of drugs, poor stability of raw materials, etc., and achieve good application prospects, solid- Strong liquid interconversion ability and good stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029]
[0030] 1. Etherification reaction
[0031] Into a round-bottomed flask were added 100 mL of ether, 19.32 g (0.05 mol) of cholesterol (compound 1-1), 6.49 g (0.055 mol) of propylene glycol monoacetate (compound 2-1), and 7.63 mL of 46.5% triacetate The ether solution of boron fluoride (0.025mol) was refluxed at 34°C for 8 hours. After the reaction, 100 mL of water was added, and ether was recovered. Using petroleum ether as the eluent, the product was separated and purified by silica gel column chromatography to obtain 19.46 g of compound 3. -1, 80% yield.
[0032] 2. Hydrolysis reaction
[0033] 100 mL of ethanol, 14.59 g (0.03 mol) of compound 3-1, 1.32 g (0.033 mol) of NaOH were added to the round-bottomed flask, and the reaction was carried out under reflux at 78°C for 4 hours. After the reaction, 100 mL of water was added, and ether was recovered to obtain 12.67 g of compound 4. -1, 95% yield.
[0034] 3. Bromination reaction
[0035] 50mL of ether, 8.88g (...
Embodiment 2
[0039] In step 4 of this example, equimolar 6-hydroxyflavone was used to replace the 7-hydroxycoumarin in step 4 of Example 1, and other steps were the same as in Example 1, and 6.23g of the small compound shown in formula 7-2 was obtained. Molecular gelling agent, yield 90%, total yield 65%.
[0040]
[0041] The structural characterization data of the obtained small molecule gelling agent are: 1 H NMR (CDCl 3 ,TMS):8.11-8.09(2H,d,J=6.11Hz),7.69(1H,d,J=8.05Hz),7.65(1H,s),7.61(3H,m),7.37-7.39(1H, d, J=3.05Hz), 7.30-7.27 (1H, dd, J=8.05Hz, J=3.05Hz), 5.37 (1H, s), 3.88-3.87 (2H, t), 3.50 (3H, m), 2.27-2.28(2H,m), 2.07-2.08(2H,m), 0.67-1.85(41H); 13C NMR (CDCl 3 ): 176.9,162.1,154.8,149.3,140.8,131.5,131.3,129.1,128.8,126.1,124.2,123.0,120.0,107.4,105.8,72.0,65.1,56.4,42.7,40.1,3,126.1,37.0 28.0, 24.4, 22.8, 21.0, 19.1, 18.5, 11.2.
Embodiment 3
[0043] In step 1 of this example, the cholesterol in step 1 of Example 2 was replaced with equimolar β-sitosterol, and other steps were the same as those of Example 2, to obtain a small molecule gelling agent represented by formula 7-3, and the total yield was 64%.
[0044]
[0045] The structural characterization data of the obtained small molecule gelling agent are: 1 H NMR (CDCl 3 ,TMS):8.11-8.09(2H,d,J=6.11Hz),7.69(1H,d,J=8.05Hz),7.65(1H,s),7.61(3H,m),7.37-7.39(1H, d, J=3.05Hz), 7.30-7.27 (1H, dd, J=8.05Hz, J=3.05Hz), 5.37 (1H, s), 3.88-3.87 (2H, t), 3.50 (3H, m), 2.27-2.28(2H,m), 2.07-2.08(2H,m), 0.67-1.85(45H); 13 C NMR (CDCl 3 ):176.9,162.1,154.8,149.3,140.8,131.5,131.3,129.1,128.8,126.1,124.2,123.0,120.0,107.4,105.8,72.0,65.1,56.4,46.0,42.7,4,1,1,37.0 28.0, 24.4, 23.4, 22.8, 21.0, 19.1, 18.5, 12.1, 11.2.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


